Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Current first-line paradigm: continuous BTKi
Constantine Tam explains continuous BTKi as the default and the desire to move toward fixed-duration oral regimens.
Play episode from 00:51
Transcript
